日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Clinical application of PARP inhibitors and emerging strategies to overcome resistance: a pan-cancer perspective

PARP抑制剂的临床应用及克服耐药性的新兴策略:泛癌视角

Xiang, Jiahui; Li, Jiayi; Guo, Zizhao; Wu, Jiang; Ma, Dongxu; Xu, Hengyi; Shang, Tongxuan; Pu, Pengming; Cong, Lin; Zhou, Ruijie; Wang, Xiang; Yu, Yingjie; Liu, Jiaqi

Lensless Quantitative Phase Imaging with Bayer-Filtered Color Sensors Under Sequential RGB-LED Illumination

基于拜耳滤波彩色传感器的无透镜定量相位成像在顺序RGB-LED照明下的应用

Wu, Jiajia; Li, Yining; Luo, Yuheng; Pan, Leiting; Song, Pengming; Xu, Qiang

Qianlie Beixi Capsules Ameliorate Diabetes-Induced Erectile Dysfunction via Modulation of the HIF-1α/VEGF Signaling Pathway: Evidence From an in Vivo Study

千烈北溪胶囊通过调节 HIF-1α/VEGF 信号通路改善糖尿病引起的勃起功能障碍:一项体内研究的证据

Sun, Longji; Lin, Zhechao; Feng, Junlong; Feng, Weidong; Mao, Pengming; Yang, Chao; Gao, Zixiang; Wang, Lu

Deep-ultraviolet ptychographic pocket-scope (DART): mesoscale lensless molecular imaging with label-free spectroscopic contrast

深紫外叠层衍射袖珍显微镜(DART):无需标记光谱对比度的介观尺度无透镜分子成像

Wang, Ruihai; Zhao, Qianhao; Quinn, Julia; Yang, Liming; Zhu, Yuhui; Huang, Feifei; Guo, Chengfei; Wang, Tianbo; Song, Pengming; Murphy, Michael; Nguyen, Thanh D; Maiden, Andrew; Robles, Francisco E; Zheng, Guoan

Targeting the CD47-HCK-LGALS9 axis disrupts proliferation-immunosuppression coupling in early-stage endometrial cancer.

靶向 CD47-HCK-LGALS9 轴可破坏早期子宫内膜癌中的增殖-免疫抑制偶联。

Ye Jingxuan, Yan Yitong, Sun Xiaoqi, Wu Qibin, Shi Yashi, Zhang Maotong, Lin Xite, Ren Yuan, Mao Xiaodan, Lin Mingyan, Sun Pengming

An Explainable Multimodal Artificial Intelligence Model Integrating Histopathological Microenvironment and EHR Phenotypes for Germline Genetic Testing in Breast Cancer

一种整合组织病理微环境和电子病历表型的可解释多模态人工智能模型用于乳腺癌种系基因检测

Yang, Zijian; Guo, Changyuan; Li, Jiayi; Li, Yalun; Zhong, Lei; Pu, Pengming; Shang, Tongxuan; Cong, Lin; Zhou, Yongxin; Qiao, Guangdong; Jia, Ziqi; Xu, Hengyi; Cao, Heng; Huang, Yansong; Liu, Tianyi; Liang, Jian; Wu, Jiang; Ma, Dongxu; Liu, Yuchen; Zhou, Ruijie; Wang, Xiang; Ying, Jianming; Zhou, Meng; Liu, Jiaqi

Correction: ERRα promotes glycolytic metabolism and targets the NLRP3/caspase-1/GSDMD pathway to regulate pyroptosis in endometrial cancer

更正:ERRα促进糖酵解代谢,并靶向NLRP3/caspase-1/GSDMD通路以调节子宫内膜癌中的细胞焦亡。

Su, Pingping; Mao, Xiaodan; Ma, Jincheng; Huang, Lixiang; Yu, Lirui; Tang, Shuting; Zhuang, Mingzhi; Lu, Zhonglei; Osafo, Kelvin Stefan; Ren, Yuan; Wang, Xinrui; Lin, Xite; Huang, Leyi; Huang, Xiaoli; Braicu, Elena Ioana; Sehouli, Jalid; Sun, Pengming

Advanced strategy for cancer detection based on volatile organic compounds in breath

基于呼气中挥发性有机化合物的癌症检测先进策略

Jia, Ziqi; Jiang, Yiwen; Shang, Tongxuan; Cao, Heng; Li, Jiayi; Cong, Lin; Pu, Pengming; Xu, Hengyi; Liu, Yuchen; Huang, Yansong; Ma, Dongxu; Wu, Jiang; Zhou, Ruijie; Wang, Xiang; Han, Chang Bao; Liu, Jiaqi

Antagonism of estrogen-related receptor-α inhibits mitochondrial oxidative phosphorylation and reduces M2 macrophage infiltration in endometrial cancer

拮抗雌激素相关受体α可抑制线粒体氧化磷酸化,并减少子宫内膜癌中M2巨噬细胞的浸润。

Jincheng Ma ,Xiaodan Mao ,Yuan Ren ,Xite Lin ,Qibin Wu ,Maotong Zhang ,Jingxuan Ye ,Shuxia Xu ,Pingping Su ,Gang Chen ,Chaoyang Sun ,Alexander Mustea ,Pengming Sun

USP25-driven KIFC1 regulates MYCBP expression and promotes the progression of cervical cancer.

USP25 驱动的 KIFC1 调节 MYCBP 表达并促进宫颈癌的进展

Ye Zhoujie, Zhu Liping, Wei Yalan, Lin Aizhu, Fan Xiaolu, Fan Xiaojing, Sun Pengming, Wang Xinrui